Synopsis
Synopsis
0
CEP/COS
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dexmedetomidine
2. Hydrochloride, Dexmedetomidine
3. Mpv 1440
4. Mpv-1440
5. Mpv1440
6. Precedex
1. 145108-58-3
2. Dexmedetomidine Hcl
3. Precedex
4. Dexdomitor
5. Dexdor
6. Sileo
7. Dexmedetomidine (hydrochloride)
8. Cepedex
9. Sedadex
10. (s)-5-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole Hydrochloride
11. (+)-medetomidine Hydrochloride
12. Dexmedetomidine Hcl (precedex)
13. Dexmedetomidine Hydrochloride [usan]
14. 4-((s)-alpha,2,3-trimethylbenzyl)imidazole Monohydrochloride
15. D-medetomidine Hydrochloride
16. Chebi:31472
17. 1018wh7f9i
18. Precedex (tn)
19. (s)-4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole Hydrochloride
20. 4-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Hydrochloride
21. 5-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole;hydrochloride
22. 145108-58-3 (hcl)
23. 1h-imidazole, 4-[(1s)-1-(2,3-dimethylphenyl)ethyl]-, Monohydrochloride
24. 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, Monohydrochloride, (s)-
25. 1h-imidazole, 5-[(1s)-1-(2,3-dimethylphenyl)ethyl]-, Hydrochloride (1:1)
26. (s)-medetomidine Hydrochloride
27. Primadex
28. Unii-1018wh7f9i
29. (s)-4-[1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Hydrochloride
30. 4-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole;hydrochloride
31. Dexmedetomidinehcl
32. Igalmi
33. Mls006011569
34. Schembl406837
35. Chembl2106195
36. Dtxsid40873215
37. Dexmedetomidine Hcl [vandf]
38. Act04745
39. 5-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Hydrochloride
40. Ac-310
41. Hy-17034a
42. Mfcd22683223
43. S2090
44. Akos024457275
45. Akos025402024
46. Bcp9000600
47. Ccg-266849
48. H08d583
49. Dexmedetomidine Hydrochloride (jan/usp)
50. As-12485
51. Dexmedetomidine Hydrochloride [mi]
52. Smr004703327
53. Bcp0726000002
54. Dexmedetomidine Hydrochloride [jan]
55. Am20080946
56. D5062
57. Dexmedetomidine Hydrochloride [mart.]
58. Sw219607-2
59. 4-((s)-a,2,3-trimethylbenzyl)imidazole Hcl
60. Dexmedetomidine Hydrochloride [usp-rs]
61. Dexmedetomidine Hydrochloride [who-dd]
62. D01205
63. Dexmedetomidine Hydrochloride [ema Epar]
64. A808325
65. Dexmedetomidine Hydrochloride [green Book]
66. Dexmedetomidine Hydrochloride [orange Book]
67. Dexmedetomidine Hydrochloride [usp Monograph]
68. Q-100166
69. Q27114321
70. Z1617901127
71. Dexmedetomidine Hydrochloride (ema Epar: Veterinary)
72. (+)-medetomidine Hydrochloride;(s)-medetomidine Hydrochloride
73. (s)-4-(alpha,2,3-trimethybenzyl)-1h-imidazole Hydrochloride
74. (s)-5-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazolehydrochloride
75. 4-((s)-.alpha.,2,3-trimethylbenzyl)imidazole Monohydrochloride
Molecular Weight | 236.74 g/mol |
---|---|
Molecular Formula | C13H17ClN2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 236.1080262 g/mol |
Monoisotopic Mass | 236.1080262 g/mol |
Topological Polar Surface Area | 28.7 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 205 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Dexmedetomidine hydrochloride |
PubMed Health | Dexmedetomidine (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Sedative |
Drug Label | Dexmedetomidine hydrochloride injection concentrate is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Dexmedetomidine hydrochloride is the S-enantiomer of medetomidine and is chemically described as (+)-4-(S)-[... |
Active Ingredient | Dexmedetomidine hydrochloride |
Dosage Form | Injectable |
Route | injection; Injection |
Strength | eq 200mcg base/2ml (eq 100mcg base/ml); 100mcg (base) /ml; 100mcg |
Market Status | Tentative Approval; Prescription |
Company | Par Sterile Products; Caraco; Mylan Institutional; Sandoz; Akorn |
2 of 4 | |
---|---|
Drug Name | Precedex |
Drug Label | Precedex (dexmedetomidine hydrochloride) injection is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Precedex (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride Injection is a sterile, nonpyrogenic ready t... |
Active Ingredient | Dexmedetomidine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 200mcg base/2ml (eq 100mcg base/ml); eq 200mcg base/50ml (eq 4mcg base/ml); eq 400mcg base/100ml (eq 4mcg base/ml) |
Market Status | Prescription |
Company | Hospira |
3 of 4 | |
---|---|
Drug Name | Dexmedetomidine hydrochloride |
PubMed Health | Dexmedetomidine (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Sedative |
Drug Label | Dexmedetomidine hydrochloride injection concentrate is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Dexmedetomidine hydrochloride is the S-enantiomer of medetomidine and is chemically described as (+)-4-(S)-[... |
Active Ingredient | Dexmedetomidine hydrochloride |
Dosage Form | Injectable |
Route | injection; Injection |
Strength | eq 200mcg base/2ml (eq 100mcg base/ml); 100mcg (base) /ml; 100mcg |
Market Status | Tentative Approval; Prescription |
Company | Par Sterile Products; Caraco; Mylan Institutional; Sandoz; Akorn |
4 of 4 | |
---|---|
Drug Name | Precedex |
Drug Label | Precedex (dexmedetomidine hydrochloride) injection is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Precedex (dexmedetomidine hydrochloride) in 0.9% Sodium Chloride Injection is a sterile, nonpyrogenic ready t... |
Active Ingredient | Dexmedetomidine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 200mcg base/2ml (eq 100mcg base/ml); eq 200mcg base/50ml (eq 4mcg base/ml); eq 400mcg base/100ml (eq 4mcg base/ml) |
Market Status | Prescription |
Company | Hospira |
For sedation of adult intensive care unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to Richmond Agitation-Sedation Scale (RASS) 0 to -3).
Non-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
Deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures.
Premedication in dogs and cats before induction and maintenance of general anaesthesia.
Alleviation of acute anxiety and fear associated with noise in dogs.
Noninvasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
Premedication in cats before induction and maintenance of general anaesthesia with ketamine.
Deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures.
Premedication in dogs before induction and maintenance of general anaesthesia.
Non-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats. Deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures. Premedication in dogs and cats before induction and maintenance of general anaesthesia.
Treatment of bipolar disorder, Treatment of schizophrenia
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
N05CM18
QN05CM18
QN05CM18
QN05CM18
QN05CM18
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?